Jason Ummel, DO
Orthopaedic Surgery · Wabash, INNPI 1063892875
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,400 of the $3,079 with a category attached, or 78.0%. Crossroads Orthopedics, LLC accounts for 81.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $2,402 and has fallen 99.3% since, to $16 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in IN, where the typical reported total is $4,533.
Across 19 payments — averaging $162.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Crossroads Orthopedics, LLC$3K
- Johnson & Johnson$193
- Stryker$104
- Sequoia Surgical, Inc.$90
- Smith+Nephew$68
- Cumberland Pharmaceuticals, Inc.$54
- plus $47 from 1 others
What the payments were for
- Food & beverage$67922%
- Education$2,40078%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Crossroads Orthopedics, LLC | 4 | $2,522 |
| Johnson & Johnson | 3 | $193 |
| Stryker | 4 | $104 |
| Sequoia Surgical, Inc. | 1 | $90 |
| Smith+Nephew | 3 | $68 |
| Cumberland Pharmaceuticals, Inc. | 2 | $54 |
| Bioventus LLC | 2 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$298
How this compares
$3,079 in reported general payments places this provider in the 40th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 32 | $1,786 |
| Tramadol Hcl | 44 | $258 |
| Methylprednisolone | 35 | $220 |
| Cephalexin | 11 | $165 |
| Oxycodone Hcl | 16 | $132 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $123 |
| Ibuprofen | 13 | $88 |
| Meloxicam | 14 | $84 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Wabash
- Frank KolisekGreenwood$7.5M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4M
- John WilliamsFort Wayne$2.7M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Mark KlaassenElkhart$1.3M
- Alan McGeeFort Wayne$1.1M
- Lindsey RolstonNew Castle$1.1M
- John MedingMooresville$998K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.